Structure-based lead optimization of novel bacterial type II topoisomerase inhibitors

被引：0
|
作者：
Pearson, Neil D.
Yang, Zheng
Bax, Benjamin D.
Gwynn, Michael N.
机构：
[1] GlaxoSmithKline Inc, Dept Antibacterial Chem, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[2] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Collegeville, PA USA
[3] GlaxoSmithKline Inc, Dept Antibacterial Microbiol, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[4] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
381-COMP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Advances in structure-based drug design of novel bacterial topoisomerase inhibitors
    Widdowson, Katherine
    Hennessy, Alan
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (11) : 1619 - 1622
  • [2] Novel DNA Topoisomerase IIα Inhibitors from Combined Ligand- and Structure-Based Virtual Screening
    Drwal, Malgorzata N.
    Marinello, Jessica
    Manzo, Stefano G.
    Wakelin, Laurence P. G.
    Capranico, Giovanni
    Griffith, Renate
    PLOS ONE, 2014, 9 (12):
  • [3] Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors
    Cooper, Ian R.
    McCarroll, Andrew J.
    McGarry, David
    Kirkham, James
    Pichowicz, Mark
    Walker, Rolf
    Warrilow, Catherine
    Salisbury, Anne-Marie
    Savage, Victoria J.
    Moyo, Emmanuel
    Forward, Henry
    Cheung, Jonathan
    Metzger, Richard
    Gault, Zoe
    Nelson, Gary
    Hughes, Diarmaid
    Cao, Sha
    Maclean, John
    Charrier, Cedric
    Craighead, Mark
    Best, Stuart
    Stokes, Neil R.
    Ratcliffe, Andrew J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (17) : 4179 - 4183
  • [4] Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors
    Lyons, Amanda
    Kirkham, James
    Blades, Kevin
    Orr, David
    Dauncey, Elizabeth
    Smith, Oliver
    Dick, Emma
    Walker, Rolf
    Matthews, Teresa
    Bunt, Adam
    Finlayson, Jonathan
    Morrison, Ian
    Savage, Victoria J.
    Moyo, Emmanuel
    Butler, Hayley S.
    Newman, Rebecca
    Ooi, Nicola
    Smith, Andrew
    Charrier, Cedric
    Ratcliffe, Andrew J.
    Stokes, Neil R.
    Best, Stuart
    Salisbury, Anne-Marie
    Craighead, Mark
    Cooper, Ian R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 65
  • [5] Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors
    D'Atanasio, Noemi
    de Joannon, Alessandra Capezzone
    Di Sante, Laura
    Mangano, Giorgina
    Ombrato, Rosella
    Vitiello, Marco
    Bartella, Cristina
    Magaro, Gabriele
    Prati, Federica
    Milanese, Claudio
    Vignaroli, Carla
    Di Giorgio, Francesco Paolo
    Tongiani, Serena
    PLOS ONE, 2020, 15 (02):
  • [6] Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors
    Ushiyama, Fumihito
    Amada, Hideaki
    Mihara, Yasuhiro
    Takeuchi, Tomoki
    Tanaka-Yamamoto, Nozomi
    Mima, Masashi
    Kamitani, Masafumi
    Wada, Reiko
    Tamura, Yunoshin
    Endo, Mayumi
    Masuko, Aiko
    Takata, Iichiro
    Hitaka, Kosuke
    Sugiyama, Hiroyuki
    Ohtake, Norikazu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
  • [7] Structure-based optimization of novel azepane derivatives as PKB inhibitors
    Breitenlechner, CB
    Wegge, T
    Berillon, L
    Graul, K
    Marzenell, M
    Friebe, WG
    Thomas, U
    Schumacher, R
    Huber, R
    Engh, RA
    Masjost, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) : 1375 - 1390
  • [8] Nonpeptide inhibitors of cathepsin G: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, Michael N.
    Hawkins, Michael J.
    Powell, Eugene T.
    Almond, Jr., Harold R.
    Corcoran, Thomas W.
    De, Garavilla, Lawrence
    Kauffman, Jack A.
    Recacha, Rosario
    Chattopadhyay, Debashish
    Andrade-Gordon, Patricia
    Maryanoff, Bruce E.
    Journal of the American Chemical Society, 2002, 124 (15): : 3810 - 3811
  • [9] Nonpeptide inhibitors of cathepsin G:: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, MN
    Hawkins, MJ
    Powell, ET
    Almond, HR
    Corcoran, TW
    de Garavilla, L
    Kauffman, JA
    Recacha, R
    Chattopadhyay, D
    Andrade-Gordon, P
    Maryanoff, BE
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (15) : 3810 - 3811
  • [10] Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design
    Jones, Spencer B.
    Pfeifer, Lance A.
    Bleisch, Thomas J.
    Beauchamp, Thomas J.
    Durbin, Jim D.
    Klimkowski, V. Joseph
    Hughes, Norman E.
    Rito, Christopher J.
    Dao, Yen
    Gruber, Joseph M.
    Bui, Hai
    Chambers, Mark G.
    Chandrasekhar, Srinivasan
    Lin, Chaohua
    McCann, Denis J.
    Mudra, Daniel R.
    Oskins, Jennifer L.
    Swearingen, Craig A.
    Thirunavukkarasu, Kannan
    Norman, Bryan H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (09): : 857 - 861
12345